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Final Summary Technical Report:   
 
US Department of Energy – Office of FreedomCar and Vehicle Technologies and US Centers for 
Disease Control and Prevention - National Institute for Occupational Safety and Health Inter-
Agency Agreement research on “The analysis of genotoxic activities of exhaust emissions from 
mobile natural gas, diesel, and spark-ignition engines”.     
 
Overview: 
 
The US Department of Energy – Office of Heavy Vehicle Technologies (now the DOE-Office of 
FreedomCar and Vehicle Technologies) signed an Interagency Agreement (IAA) with NIOSH, 
#01-15 DOE, 9/4/01, for "The analysis of genotoxic activities of exhaust emissions from mobile 
natural gas, diesel, and spark-ignition engines"; subsequently modified on 3/27/02 (DOE 
IAG#01-15-02M1); subsequently modified 9/02/03 (IAA Mod # 01-15-03M1), as “The analysis 
of genotoxic activities of exhaust emissions from mobile internal combustion engines:  
identification of engine design and operational parameters controlling exhaust genotoxicity”.  
The DOE Award/Contract number was DE-AI26-01CH11089.  The IAA ended 9/30/06.   
 
This is the final summary technical report of National Institute for Occupational Safety and Health 
research performed with the US Department of Energy – Office of FreedomCar and Vehicle 
Technologies under that IAA: (A) NIOSH participation was requested by the DOE to provide in vitro 
genotoxicity assays of the organic solvent extracts of exhaust emissions from a suite of in-use diesel or 
spark-ignition vehicles; (B) research also was directed to develop and apply genotoxicity assays to  the 
particulate phase of diesel exhaust, exploiting the NIOSH finding of  genotoxicity expression by diesel 
exhaust particulate matter dispersed into the primary components of the surfactant coating the surface of 
the deep lung; (C) from the surfactant-dispersed DPM genotoxicity findings, the need for direct 
collection of DPM aerosols into surfactant for bioassay was recognized, and design and developmental 
testing of such samplers was initiated.   
 
DISCLAIMER 
 
This report was prepared as an account of work sponsored by an agency 
of the United States Government. Neither the United States Government 
nor any agency thereof, nor any of their employees, makes any warranty, 
express or implied, or assumes any legal liability or responsibility for 
the accuracy, completeness, or usefulness of any information, apparatus, 
product, or process disclosed, or represents that its use would not 
infringe privately owned rights. Reference herein to any specific 
commercial product, process, or service by trade name, trademark, 
manufacturer, or otherwise does not necessarily constitute or imply its 
endorsement, recommendation, or favoring by the United States Government 
or any agency thereof. The views and opinions of authors expressed 
herein do not necessarily state or reflect those of the United States 
Government or any agency thereof. 
 
 
(A)  Bacterial mutagenicity assays and mammalian cell in vitro genotoxicity assays for chromosomal or 
DNA damage were performed on the organic solvent extracts of exhaust particulate matter (PM) and 
semi-volatile organic compounds (SVOC) collected from a random set of spark-ignition or diesel engine 
vehicles at the Southwest Research Institute (SwRI) in the DOE study; the engines were run on a 
standardized engine loading and speed driving cycle on a dynamometer at SwRI; and chemical and non-
genotoxicity bioassays were performed on the exhaust materials by other DOE-affiliated laboratories 
(Desert Research Lab; Lovelace Respiratory Research Institure), referenced in [1] and [2].  The NIOSH 
genotoxicity studies were performed upon organic solvent extracts: of a combined diesel vehicle exhaust 
PM sample; a combined spark-ignition engine vehicle exhaust PM sample; and the matched pair of 
SVOC samples. NIOSH performed in vitro bioassays for gene mutation in bacteria, chromosomal 
damage as micronucleus (MN) induction in mammalian cells, and DNA damage by the single cell gel 
electrophoresis method in mammalian cells.   
 
For these particular vehicles, the solvent extracts of the exhaust materials on a per unit mass basis were 
more active for the spark-ignition vehicles than for the diesel vehicles.  However, on a fuel consumption 
basis, the diesel exhaust activity was greater. [3,4].  A caveat to the interpretation of these results is the 
is the differences in age and mileage of these particular vehicles. [2].  This NIOSH laboratory also has 
collaborated with other US Department of Energy research on bacterial mutagenicity studies of the 
organic solvent extract of filter-collected DPM, but from an industrial-scale stationary diesel engine 
operated on standard diesel fuel DF2, and on a Fischer-Tropsch synthesis fuel, mapping broad changes 
in bacterial mutagenic activity versus engine speed and loading. Steady-state conditions. [McMillian 
MH, Cui M, Gautam M, Keane M, Ong T, Wallace W, and Robey E.  Society of Automotive Engineers 
Technical Paper 2002-01-1699, pp. 1-18 , 2002].   
 
(B) In addition to these studies of the organic solvent extracts of diesel exhaust components, DOE-
NIOSH IAA research measured in vitro genotoxic activities of whole, non-solvent-extracted DPM, 
using a NIOSH research method for in vitro genotoxicity assay of DPM dispersed into a principal 
component of the surfactant that coats the airway surface of the deep lung.[5,6,7].  
 
NIOSH research has found that when DPM is mixed into an aqueous dispersion of a phospholipid 
component o lung surfactant, the material coating the air-interface of the pulmonary alveoli and 
respiratory bronchioles, then the particles are able to express their genotoxic activities in vitro.  That is, 
the diesel soot particles are not dissolved, but are active as surfactant coated and dispersed particles.  
This provides a method to retain particle structure and its effects on the expression of toxicities, 
modeling the conditioning and activity of respired particles depositing on the lung deep airways.  The 
soot particles adsorb surfactant onto their surfaces from aqueous dispersion, making the so-conditioned 
particle surfaces hydrophilic and permitting the soot particles to disperse aqueous media.     
 
Bacterial mutagenicity assays and mammalian cell mutagenicity, clastogenicity, and DNA-damage 
assays have been performed for DPM supplied by the Lovelace Respiratory Research Institute from the 
automotive diesel engine system used in DOE in vivo inhalation exposure animal model studies of 
diesel exhaust-induced lung tumors in rodents [5,6], and from National Institutes of Standards and 
Technology (NIST) standard reference material diesel soot SRM 2975 [7].  Both DPM expressed 
bacterial mutagenicity and mammalian cell clastogenic or DNA-damage activity for both solvent extract 
and surfactant dispersion preparations.   
 
The findings of the studies of surfactant-dispersed DPM in vitro genotoxicity may be summarized: 
Whole non-extracted diesel exhaust particulate can express in vitro genotoxic activities when dispersed 
into a model lung surfactant.  That activity of whole surfactant-dispersed ultrafine diesel exhaust 
particles can be comparable to the activity of their extracted organics in bacterial mutagenicity assay.  In 
some cases, the whole DPM dispersed in surfactant expresses much greater chromosomal or DNA 
damaging activity that expresses by the organics extracted from an equal mass of DPM.  That is, 
genotoxic activity can be exacerbated when the genotoxic compounds are associated with otherwise 
inert carrier ultrafine particles. 
 
(C) From the results of these surfactant-mediated in vitro DPM genotoxicity studies, research 
was begun under this IAA to develop an aerosol sampler to collect respirable DPM from the 
exhaust or the atmosphere directly into surfactant.  This is to permit bioassay of the exhaust 
materials so as to retain their ultrafine nano-structure and to avoid anomalous physical or 
chemical conditioning of the particles during collection.  A concept was developed for a system 
for direct sampling DPM into surfactant [8], and a preliminary quantitative test of a method was 
begun under this IAA.  This involves the collaboration of NIOSH, US Dept. of Energy, West 
Virginia University, and University of Southern California researchers.  This is being pursued 
under a new DOE-FCVT – NIOSH IAA begun in late FY06: US Department of Energy – 
NIOSH Interagency Agreement (IAA) #06-08: DE-A126-06NT42821: “Novel collection and 
toxicological analysis techniques for IC engine exhaust particulate matter”.  
 
The DOE-NIOSH IAA work is summarized in limited detail in the following report.  Further 
details can be found in the available scientific literature generated in these studies which is 
referenced and listed at the end of this report.  This consists of peer-reviewed technical journal 
publications, and juried scientific conference presentations for which the power-point 
proceedings are available electronically on the web. Additional questions can be addressed to the 
NIOSH Principal Investigator, William E Wallace, PhD, NIOSH, 1095 Willowdale Road, 
Morgantown, WV, 26505. Phone (304) 285-6096; wwallace@cdc.gov.          
 A. Comparative In vitro genotoxicity of Exhaust Emissions of In-Use Diesel and Gasoline 
Engine Vehicles Operated on a Unified Driving Cycle 
 
As part of a US Department of Energy multi-institutional study of the exhaust toxicities of 
modern gasoline, diesel, and natural-gas mobile vehicle engines, NIOSH performed in vitro 
bioassays for gene mutation in bacteria, chromosomal damage as micronucleus (MN) induction 
in mammalian cells, and DNA damage by the single cell gel electrophoresis method in 
mammalian cells, on solvent extracts of diesel or gasoline engine exhaust particulate matter (PM) 
or vapor-phase semi-volatile organic compounds (SVOCs) for a set of vehicles in-use circa 2000 
(Table 1).  The was done in concert with chemical analyses [B. Zielinska, J. Sagebiel, J. 
McDonald, K. Whitney and D. Lawson,  J. Air and Waste Mgt. Assoc., 2004, 54, 1138] and 
other toxicological analyses [J. C. Seagrave, J. D. McDonald, A. P. Gigliotti, K. J. Nikula, S. K. 
Selikop, M. Gurevich and J. L. Mauderly, Toxicol. Sci., 2002, 70, 212] of parallel samples of the 
same engine exhaust materials performed by other DOE –FCVT program contractors. 
 
The study was designed to address in part the question of the in vitro genotoxic activities of 
exhaust emission materials from some typical recent-use spark-ignition gasoline engine and 
diesel engine light duty vehicles.  It should be noted that mobile vehicle engines are in a state of 
rapid evolution and improvement in emissions reduction technology so the vehicles sampled in 
this study do not represent the best emission control capabilities now available. Diesel PM 
emission rates observed in this study are much higher than those which will be permitted under 
USEPA regulations being phased-in in 2007 for new diesel vehicles.  
 
Acetone extracts of engine exhaust particulate matter (PM) and of vapor-phase semi-volatile 
organic compounds (SVOCs) collected from a set of 1998-2000 model year normal emitter 
diesel engine automobile or light trucks and from a set of 1982-1996 normal emitter gasoline 
engine automobiles or light trucks operated on the California Unified Driving Cycle were 
assayed at 720F or at 300F ambient temperature for in vitro genotoxic activities. Comparison 
measurements were made also on the extract of a standard diesel exhaust particulate material:  
National Institute of Standards and Technology (NIST) Standard Reference Material SRM1650a, 
typical of heavy-duty diesel engine particulate emissions of the early 1980s.  Experimental 
design and results are briefly reviewed here.  Details can be found in the references [1,3,4].  
 
 
 
Table 1. Exhaust samples were collected from five gasoline engine vehicles and three diesel 
engine vehicles a, 
 Vehicles  Year   Model   Odometer reading 
Gasoline engine: 
    1982  Nissan Maxima   190,203 
    1993  Mercury Sable    70,786 
    1994  GMC 1500 pickup truck  68,325 
    1995  Ford Explorer    76,733 
    1996  Mazda Millenia   35,162 
Diesel engine: 
    1998  Mercedes Benz E300   47,762 
    1999  Dodge 2500 pickup truck  37,242 
    2000  Volkswagen Beetle TDI  7,455 
a Four pooled samples were prepared for assay: gasoline exhaust PM or SVOC; diesel exhaust 
PM or SVOC. 
 
 
Table 2. Mutagenic activity per mass of extract and per vehicle mile for GP, DP, GSVOC, 
DSVOC, and NIST SRM 1650a, 720F ambient temperature.   
 
 
Factor Combination Group   Slope Estimate   Slope Estimate 
      (Revertants/μg extract)  (Revertants x 103/mile) 
 
  
YG1024 - S9  GP (gasoline)   59.5A   440  
   DP (diesel)   56.8A   2866 
   G-SVOC       6.1   13.9 
   D-SVOC     1.9   36 
   NIST (SRM 1650a)  72.2 A   - 
 
YG1024 + S9  GP    39.0 B   289 
   DP    32.5 C   1640 
   G-SVOC    4.9   11.2 
   D-SVOC    1.4   26.6 
   NIST    46.3 BC   - 
            
YG1029 - S9  GP    19.4 D   144 
   DP    13.1   661 
   G-SVOC   5.7   13 
   D-SVOC   1.0   19 
   NIST    21.8 D   - 
 
YG1029 + S9  GP    17.7   131   
   DP    43.3 E   2185 
   G-SVOC     5.2   11.9 
   D-SVOC    1.8   34.2 
NIST    35.3 E   - 
 Table entries having the same superscript labels (A through E) are not significantly 
different (p<0.05) 
 
 
Figure 1: Fraction of damaged cells from the SCGE assay vs. dose: (a) dose as μg extract/ml of 
culture medium; (b) dose as vehicle miles/ml of culture medium, 720F ambient temperature runs.     
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Error bars are standard error of the means: N=8 for all gas & diesel PM and SVOC; 
N=12 for NIST.  The abscissa scale is logarithmic. Values for the negative controls (zero 
dose) are shown on the ordinate. 
 
 
Figure 2: Micronucleus induction expressed as micronucleated cells/1000 V79 cells vs. dose 
expressed as (a) μg extract/ml of culture medium or as (b) vehicle miles/ ml of culture medium, 
720F ambient temperature runs.    
 
                                       (a)                                                                          (b) 
Dose, μg/ml
10 100
M
ic
ro
nu
cl
ea
te
d 
ce
lls
/1
00
0 
ce
lls
0
20
40
60
80
100
Gasoline PM 
Diesel PM 
Gasoline SVOC 
 Diesel SVOC 
NIST PM 
Dose, vehicles miles/1000
0.1 1 10
M
ic
ro
nu
cl
ea
te
d 
ce
lls
/1
00
0 
ce
lls
0
20
40
60
80
100
Gasoline PM 
Diesel PM 
Gasoline SVOC 
Diesel SVOC 
 
 
Error bars are standard error of the means: N ranging from 2 to 5.  The abscissa scale 
is logarithmic. Values for the negative controls (zero dose) are shown on the ordinate. 
Table 3. Mutagenic activity (revertants/ microgram of extract or kilo-revertants/vehicle mile) for 
D8 (Gasoline) or D9 (Diesel) particulate matter (PM) or semi-volatile organic compounds 
(SVOC) and NIST SRM 1650a, 300F ambient temperature.   
 
YG1024-S9  YG 1024+S9  YG1029-S9  YG1029+S9 
   
  Rev/ug kR/mile  R/ug kR/mile  R/ug kR/mile  R/ug kR/mile 
  
D8 PM  33.8 574.6  39.5 671.5  14.7 250  30 510  
           
D8 SVOC 5.6 37  2.5 16.5  6.8 44.9  2.8 18.5  
           
D9 PM  90.1 14506  164 26404  29.5 4750  95 15295  
           
D9 SVOC 7.1 339.7  9.2 440.2  8.5 406.7  13.8 660.3   
           
NIST  54 NA  48.1 NA  22.3 NA  51.5 NA 
  
 
Figure 3: Micronucleus induction expressed as micronucleated cells/1000 V79 cells vs. dose 
expressed as μg extract/ml of culture medium, 300F ambient temperature runs; (a) PM; (b) 
SVOC).    
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Figure 4: Fraction of DNA-damaged cells from SCGE assay vs. dose as μg extract/ml of culture 
medium; 300F ambient temperature runs; (a) PM; (b) SVOC).  
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 All fractions of all materials, PM and SVOC, were highly mutagenic in the Salmonella reversion 
assays in both tester strains and conditions of the assay, with and without microsomal activation. 
Mutagenic activities expressed were similar on a mass basis for the gasoline and diesel engines 
particulate extracts; mutagenic activities of the NIST SRM particulate material extract, which 
represents older, 1980s diesel technology, were somewhat stronger.  When normalized to doses 
based on vehicle miles, however, the mutagenicity versus dose slope estimates become much 
larger for the diesel exhaust, based on the greater engine exhaust emission production rate, often 
almost an order of magnitude greater for the diesels versus the spark-ignition engine emissions.  
The SVOC extracts in general were far less potent mutagens than were the PM extracts.  The 
effect of the S9 microsomal fraction was complex, with the YG 1024 strain generally showing 
very similar or smaller dose-response mutagenicity slopes with the S9 addition, while the 
YG1029 strain did show significantly increased responses for the diesel particulate and SVOC 
extracts with microsomal fraction addition. The gasoline and diesel exhaust extracts both 
induced both frameshift and base-pair substitution mutations, with the diesel more active for the 
latter type.  These results generally indicate that in vitro bacterial genotoxic activities of engine 
exhaust materials can be comparable on a mass of extract basis for spark-ignition gasoline 
engines and diesel engines, but were much stronger for these diesels on a mileage basis because 
of the much higher emission rates per mile for the diesel vehicles in this study.    
 
Mammalian cell assays for DNA or chromosomal damage exhibited some qualitative differences 
between the diesel and gasoline extract samples distinct from the bacterial cell findings.  DNA 
damage as measured by the SCGE “comet” assay was positive for gasoline engine exhaust PM, 
but diesel PM was comparatively weak on a mass basis, while comparable on a mileage basis, as 
shown in Fig. 1.  Micronucleus induction in V79 cells did not parallel the SCGE results for all 
samples: the gasoline PM and gasoline SVOC extract activities for micronucleus induction were 
similar on a mass basis; this was the only case where SVOC activity approached that of the 
corresponding PM extract activity.  Gasoline PM was much stronger than diesel PM extract for 
micronucleus induction on a mass basis, but was comparable on a mileage basis.  However, 
diesel SVOC was inactive for micronucleus induction.  The NIST sample was positive in this 
micronucleus assay, but with complex dose-response behavior, with activity initiating at the 
middle dose level.  The results indicate that these gasoline engine exhaust materials were much 
stronger than the diesel exhaust materials on a mass basis for some mammalian cell genotoxic 
activities, with the gasoline exhaust activities comparable to or sometimes greater than the diesel 
exhaust activities on a mileage basis.  This is not inconsistent with literature reports of some past 
studies of earlier generation vehicles, which saw significant mammalian cell genotoxic activities 
for gasoline engine exhaust extracts. One significant difference in the older studies was their use 
of leaded gasoline fuel, standard at the time. The NIOSH study suggested that leaded fuel use is 
not necessary for the production of gasoline exhaust extract genotoxic activity.  
 
The chemical characterization work of Zielinski et al., 2004, on these materials found that the 
diesel exhaust particulate fraction contained much higher levels of nitro-polyaromatic 
hydrocarbon compounds (nitro-PAHs), which have been demonstrated to be a major contributor 
to the mutagenicity of diesel exhaust in the Salmonella mutagenicity assay.  The detailed 
chemical analysis of the gasoline engine exhaust analytes showed generally lower concentrations 
of most relative to diesel exhaust, with the exception of PAHs, especially high molecular weight 
compounds such as indeno[cd]perylene, benzo[ghi]perylene, and coronene, which has also been 
observed in earlier studies.  This may at least partially explain why the micronucleus and SCGE 
assay results were consistently stronger for the gasoline exhaust PM, while the diesel PM was 
comparable on a mass basis in the Salmonella mutagenicity assay.  Additional fractionation and 
preparation would be required before genotoxicity studies could test this hypothesis. 
 
Genotoxic activities of exhaust products from these or any vehicles can be expected to change 
with the specific mode of operation.  Under steady state operating conditions, diesel exhaust 
genotoxic activity can be strongly affected by conditions of operation, e.g., engine torque, rpm, 
and fuel injection timing [M. H. McMillian, M. Cui, M. Gautam, M. Keane, T. Ong, W. Wallace 
and E. Robey,  Society of Automotive Engineers Technical Paper 2002-01-1699, pp. 1-18].   
Detailing the effects on exhaust genotoxicant composition of these engine operational 
parameters, or of changing these parameters during vehicle operation as in acceleration, 
deceleration, or conditions of changing load, would require a different experimental design.  
Other factors that may affect the emissions include the fuel used and the effects of engine and 
exhaust aftertreatment system design; and vehicle age and maintenance can greatly affect 
emissions, e.g., “white smokers” and “black smokers”.   
 
 
B. Analyzing Diesel Exhaust for Ultrafine Particle Structure and Composition Factors Affecting 
Toxicity. 
 
Diesel exhaust control technology is rapidly evolving.  Compared to the PM emission rates seen 
in the in-use vehicle study (above), significant reductions are mandated by the USEPA for 2007 
to 2009 model years.  While the new systems are being developed principally to meet the new 
EPA NOx and fine PM standards, there is the possibility that ultrafine (particle size below 0.1 
micrometer) exhaust particles may be emitted from the new systems.  There is a general concern 
in industry for new “nanoparticle” technologies:  there is limited animal model evidence that 
some materials may have enhanced toxicities or present exacerbated health risk as ultrafine 
particles in contrast to their more limited toxic properties as respirable fine (micrometer-sized) 
particles.  The above studies and essentially all in vitro assay results for diesel exhaust material 
reported in the scientific literature have been performed upon the organic solvent (e.g., acetone) 
extracts of filter-collected DPM.  That is, the assays were performed upon chemicals dissolved 
out of the diesel exhaust particles; any effects of the particulate structure and complex 
composition of the particles are destroyed prior to the assay.   
 
It had been suggested that the genotoxicant chemicals associated with DPM would not express 
their genooxtic activities if they were not extracted from the particles.  And it was found that, 
unlike acetone or other organic solvents, the fluid coating the surface of the deep lung could not 
efficiently extract genotoxic chemicals from diesel soot particles.  Thus the physiological 
significance of assays of materials solvent-extracted from diesel soot was questionable from the 
standpoint of representing the biological availability of the hydrophobic organic genotoxicants 
which would remain particle-bound in the lung.   
 
That is, in vitro bioassays of organic solvent extracts of DPM appear not to model the biological 
availability in the lung of particle-bound organic genotoxicants.  The in vivo physiological 
situation is this:  upon depositing in the deep lung airspaces, particles first will encounter the thin 
alveolar hypophase, a liquid lining of the deep lung airspaces which is spread with pulmonary 
surfactants upon the air-liquid interface and which contains surfactants dispersed in micellar and 
lamellar forms within the liquid layer on the respiratory bronchioles and terminal alveoli.  
Studies have demonstrated that the primary components of lung surfactant do not extract 
materials with strong in vitro genotoxic activity from DPM.  Research frequently uses a 
surrogate for lung surfactant consisting of a primary phospholipid component of lung surfactant, 
diacyl phosphatidylcholine, typically dipalmitoyl phosphatidylcholine (DPPC), dispersed into 
physiological salt-concentration saline.  In addition to being a major chemical constituent of lung 
surfactant, DPPC as a surfactant layer at the water-air interface reproduces the principal surface 
tension altering effects of whole lung surfactant.   The inability of a DPPC-in saline dispersion 
model of lung surfactant to extract organic genotoxicants DPM raised the question of whether 
the genotoxicants in insoluble hydrophobic DPM are able to express their activity under 
conditions of deposition in the lung.   NIOSH research has found that mixing DPM into a DPPC-
in-saline dispersion without filtering results in a surfactant dispersion of DPM that expresses in 
vitro genotoxic activity.  That is, when diesel soot is mixed into the DPPC-in-saline surfactant, 
organic genotoxic chemicals are not extracted from the soot particles; but instead, the particles 
are coated with the surfactant.  They thus acquire a hydrophilic surface, and they are solubilized, 
not dissolved, into a dispersion in saline, retaining their ultrafine particle structure.  The surface 
conditioning of the ultrafine particles that have adsorbed surfactant provides a plausible model of 
the surfactant surface-conditioning the particles would experience upon deposition in the lung.  
Furthermore, NIOSH research found that bacterial gene mutation activity expressed by the 
surfactant-dispersed (not extracted) DPM was quantitatively comparable to that expressed by 
organic solvent extracts of equal amounts of DPM, in assays of bacterial gene mutations.  This 
addresses the question of how a hydrophobic particle-bound genotoxicant can be biologically 
available for genotoxic activity in the lung without dissolution; and it provides the basis for a 
bioassay protocol to determine ultrafine particle structural effects on the expression of genotoxic 
activity.   
 
Surfactant-mediated in vitro genotoxicity testing of DPM was carried out to provide a capability 
for physiologically representative short-term in vitro genotoxicity testing of DPM while retaining 
ultrafine particle characteristics; and to develop a capability for collection of DPM directly into 
model lung surfactant in order to avoid possible chemical adulteration of DPM during sampling 
[5,6,7].  Such possible adulteration includes chemical modification of DPM resident on the 
collection filter during sampling by exhaust gases passing through the filter; and possible 
irreversible physical agglomeration of ultrafine particles during capture on the filter.  In vitro 
genotoxicity assays for chromosomal aberrations (CA), micronucleus formation (MN), and gene 
mutation in V79 cells of solvent extract and of surfactant dispersion of an older automotive 
diesel engine soot were reported for a sample of DPM, graciously provided earlier by the 
Lovelace Respiratory Research Institute, that had been filter-collected from the dilution tunnel of 
a system used for chronic exposures of animals to whole diesel emissions.  Exhaust was 
generated by 1980 Model General Motors 5.7 L V-8 engines operated on test stands over 
continuously repeating Federal Test Procedure urban duty cycles and burning certification D-2 
Diesel Control Fuel.   
 
For the preparation of surfactant dispersion, 100 mg DPPC was sonicated into 10 ml of 0.85% 
physiological sterile saline (PSS).  For the DPM in DPPC dispersion, 25 mg of each DPM 
sample was mixed at 37°C into 2.5 ml of 10 mg DPPC/ml in PSS.  For comparison solvent 
extracted samples, dimethyl sulfoxide (DMSO) dispersion of DPM was similarly prepared.  
Aliquots of these stock preparations were added to Eagles' Minimal Essential Medium to provide 
the DPM concentrations of 25 to 150 ug/ml in the cell systems.  
 
After 72 h challenge of V79 mammalian-derived cells, chromosomal aberration were read on  
one hundred well-spread metaphases for each treatment, for chromatid gaps and breaks, 
isochromatid gaps and breaks, fragments, deletions, minutes, acentric ring, dicentromere and 
endoreduplications.  The frequencies of CA's with and without gaps were compared to the 
solvent control (DPPC or DMSO) and to a positive control, N-methyl-N’-nitroso-N-
nitrosoguanidine (MNNG), using a X2 test. Treatment with DPM in DPPC dispersion in saline 
significantly increased the number of aberrant cells at concentrations of 25 to 150 ug/ml, with the 
effect generally increasing with concentration. (Table 5). A parallel elevation in the total number 
of CA was also observed.  The difference between treated and control groups, both with and 
without gaps, was statistically significant. 
  
Micronucleus induction in a similarly prepared V79 cell system was determined after 24-hr 
treatment.   Micronucleated cells (MN) in treated and control cells were scored.  A criterion for 
MN scoring was that their diameter must be no larger than one-third of that of the main nucleus.  
The frequency of MNC, expressed as the number of MNC cells per 1000 cells, was determined 
by counting 1000 cells on 6 separate slides for each treatment. DPM in DPPC induced MN 
formation activity that generally increased with concentration and was statistically significant at 
the highest concentration tested.  DPM in DMSO significantly increased MN formation in V79 
cells at all but the lowest concentration, with activity increasing with concentration (Table 6).   
 
For assay of induction of 6-thioguanine-resistant forward mutation in eukaryotic cells, V79 cells 
were similarly prepared and incubated with DMSO or DPPC preparations of DPM for 24 h, and 
then after 7-day expression time, 6-TG/ml was added.  Survival was measured after 10 days to 
estimate mutations.  Table 7 gives the frequency of TG mutants obtained in the groups treated 
with DPM in DPPC-saline and also in DMSO.  The results show that neither preparation 
significantly affected the frequency of TG mutants.  This was confirmed in a repeated 
experiment.  Data on relative survival, Table 5, indicate that DPM was toxic to V79 cells only at 
the highest concentration (150 µg/ml) tested. 
 
These findings confirmed that genotoxic activity associated with diesel particles inhaled into the 
lung may be bioavailable by virtue of the dispersion properties of pulmonary surfactant 
components.  Both CA and MN in vitro assays showed genotoxic responses for DPM dispersed 
in DPPC in saline, a primary component of pulmonary surfactant.  CA analysis was more 
sensitive than the MN assay to the DPM.  In vitro MN testing with mammalian cells such as V79 
cells may provide a simple assay for screening the genotoxicity of diesel samples. Neither DPPC 
nor DMSO dispersion of DPM produced a mutagenic response in the in vitro TG gene mutation 
assay using V79 cells. This is consistent with literature reports of insensitivity of V79 cells to 
diesel soot in this assay.   
 
Numerous conventional short-term in vitro assays of individual organic compounds have shown 
good sensitivity and specificity for correlation of assay results with in vivo tumorogenesis.  
Surfactant conditioning demonstrated can extended such in vitro bacterial and mammalian cell 
testing to insoluble NP materials.  The NIOSH results indicate dispersion in phospholipid 
surfactant of 5 to 10 mg DPPC per square meter particulate material surface area can permit full 
expression genetic toxicity in mammalian cell assays.  In vivo, pulmonary surfactant is well in 
excess of amounts needed to provide such adsorption and solubilization of respired NP.  By 
calculation from literature values of  the amount of lavageable lung surfactant and the half life 
time of surfactant replacement,  lung surfactant is in quantity to solubilize some 100 times or 
more of the DPM that would be respired under occupational exposures at the ACGIH proposed 
exposure limit of 0.1 gm DPM per workday.    
Table 5. Chromosomal Aberrations (CA) Induced by DPM in V79 Cells 
_________________________________________________________________________________________ 
Aberrant     CA / 100 Metaphase a                                      Total CA b 
                     Conc.     Cells  _______________________________________     _______________    
Treatment            µg/ml   (%)  Chromatid         lsochromatid  With   Without  
    ________    _____________________________  Gaps    Gaps  
     G  B M  F    G B M  TD  AC  DC  IC  N   Other   
________________________________________________________________________________________ 
 
DPPC a    0.1 10           6   2  0  0     1  0  0     0     0      1    0    0        0   10  3 
DPM a in DPPC  25 27c 11  0  0  0     3  0  3     5     0     5     0    1        0             28c 14c 
DPM in DPPC 50 35c 12  6  0  0     8  0  1     6     0     2     1    1        1   38c 18c 
DPM in DPPC 100 33c 15  3  1  6     9  0  1     2     1     3     1    0        1   43c 19c  
DPM in DPPC 150 43 c        14   7  0  0   11 4  0      5     0     6     0    1        4             52c       27c 
MNNG a   1 62 c        24  21 0  6    4  7  4      5     1   13     1    4        5   95c        67c 
_________________________________________________________________________________________ 
aAbbreviations: G, gaps; B, breaks; M, minutes; F, fragments; TD, terminal deletions; AC, accentric rings; DC,  
dicentric chromosomes;  IC, interchanges; N, numerous aberrations; Other, including endoreduplication and  
polyploidy; DPPC, dipalmitoyl phosphatidylcholine; DPM, diesel particulate material; MNNG, N-methyl-N’-
nitroso-N-nitrosoguanidine.  
b 100 metaphases scored 
c p<0.05 by χ2 test 
 
Table 6. Frequency of micronucleated cells (MNC) in V79 cells treated with DPM for 24 hours  
_________________________________________________________ 
Chemical    Concentration     Frequency of MNCa      Total number  
Total Number          μg/ml                 mean ±SD          of MNCb 
_________________________________________________________ 
DPPCc             5  5.7±0.82       34  
DPMc in DPPC          25  6.5±1.05       39  
DPM in DPPC           50  8.2±1.33       49  
DPM in DPPC           100  6.8±1.47       41   
DPM in DPPC           150  9.5±1.64       57e 
DMSOc             5d  6.5±2.51      39  
DPM in DMSO           25  5.2±1.60      31  
DPM in DMSO           50  13.3±1.75      80e  
DPM in DMSO           100  11.8±1.94      79e 
DPM in DMSO           150  14.2±1.72        85e  
MNNGc              1  48.0±5.55      288e  
____________________________________________________________________________________ 
aMNC per 1000 cells; n=6.  
bBased on 6000 cells scored in each of 2 experiments. 
cAbbreviations: DPPC, dipalmitoyl phosphatidylcholine; DPM, diesel particulate material; 
DMSO, dimethyl sulfoxide; MNNG, N-methyl-N’-nitroso-N-nitrosoguanidine. 
dConcentration in μ1/ml. 
eDifferent from solvent control (DPPC or DMSO) at p < 0.05  
Table 7. Results of 6-thioguanine-resistant gene mutation assay for DPM in V79 cells 
_____________________________________________________________________ 
Chemical  Concentration       Relative Survival             Mutants  
       (µg/ml)      (%)         per 106 Survivors  
_____________________________________________________________________ 
DPPCa   5  100±9.5  6.1±1.3 
DPMa in DPPC 25  174.9±29.2  6.6±2.4 
DPM in DPPC 50  133.0±18.7  3.3±2.1  
DPM in DPPC 100  105.2±13.1  10.8±3.1 
DPM in DPPC 150  82.8±12.6  2.5±1.4 
DMSOa  5 b   100±4.9  6.2±2.9 
DPM in DMSO 25  38.8±13.4  6.1±1.9 
DPM in DMSO 50  115.1±11.4  5.5±2.3 
DPM in DMSO 100  99.4±7.9  9.1±5.6 
DPM in DMSO 150  83.8±10.1  7.8±3.4 
MNNGa  1  15.5±3.0  114.9±19.8 
 
a See footnote c in Table 2 for abbreviations. 
bConcentration in µl/m1 
  
  
 
 
 
 
A concern for the extrapolation from in vitro genotoxic activity to possible disease hazard, 
including the case of surfactant-dispersed DPM, is that DPM induction of lung tumors in animal 
models has been under conditions of “particle overload” exposures rather than under conditions 
representative of occupational exposures.  Conditions of in vitro cell challenge leading to 
induction of genotoxic activities have usually been at DPM-to-cell concentrations far exceeding 
doses conferred by one day of exposure at the ACGIH limit of 0.1 mg per workday.  However, 
incomplete lung clearance or sequestration of DPM within pulmonary cells can lead to 
increasing lung loads of DPM with increasing exposure times.  This has been reported in the 
literature for inhalation exposures of the rat to 0.25 mg to 6 mg DPM per cubic meter of air, 
which resulted in residual lung burdens after 7 to 112 days of 0.2 to 12 mg retained DPM.  Such 
amounts would be modeled for in vitro study by concentrations in the range of 1 to 10 
microgram DPM per square centimeter of plated cells, which are within concentrations used in 
these NIOSH-DOE in vitro mammalian cell studies of surfactant-dispersed DPM, which show 
clastogenic and DNA damage.  
 
Further research on surfactant-dispersion and genotoxicity testing on DPM was begun under this 
IAA on a reference material from the US National Institute for Standards and Technology 
(NIST).  This was to provide information on a “positive control” DPM for other research labs 
that might pursue surfactant-mediated diesel genotoxicity studies in support of diesel engine 
technology development.  Preliminary results were peer-review selected for presentation at the 
2006 DOE-sponsored Diesel Engine Efficiency and Emission Control Research Conference. The 
presentation materials are available on the web [7].  The NIST diesel soot was assayed for 
bacterial mutagenicity and mammalian cell DNA damage and chromosomal damage, as an 
acetone/dimethylsulfoxide extract and as a dispersion into DPPC/saline.  For this particular soot, 
the mammalian cell assays of micronucleus induction and single cell gel electrophoresis measure 
of DNA single or double strand breaks, resulted in much higher expression of genotoxicity for 
the surfactant-dispersed particles in comparison to the activity of the extracted genotoxicants.  
That is, on a mass basis, genotoxic activity to mammalian cells was exacerbated for the case of 
the genotoxicants bound to ultrafine particles.    
 
Bacterial mutagenicity assay of filter-collected NIST Diesel Exhaust Standard Material 2975 
used the “micro-suspension” mode of the histidine reversion gene mutation assay in Salmonella 
typhimurium YG1024 or YG1029, with or without microsomal enzyme activation. Surfactant 
dispersion used DPPC ultrasonically dispersed in physiological sterile saline at a concentration 
of 2.5 mg DPPC / ml PSS.  DPM was mixed into the dispersion at a concentration of 1 mg DPM/ 
2.5 mg DPPC / 1 ml PSS.   This stock dispersion then was diluted with PSS to provide samples 
of 13.3, 40, 120 microgram DPM in 10 micro-liter PSS. The solvent preparation was made by 
acetone extraction, evaporation, and dissolution into dimethylsulfoxide (DMSO) at 2 mg DPM 
extract / ml DMSO. Dilution with PSS provided samples of 13.3, 40, 120 microgram extract in 
10 microliter PSS.  The test protocol for the micro-suspension test was: mix samples of0.0133, 
0.040, 0.120 mg DPM or solvent-extract of DPM in 0.01 ml PSS,  add .065 ml PSS or S9 
preparation, add .025 ml of YG1024 or YG1029 @ 1-2 x 108 cells/ml; preincubate the mixture 
30 minutes at 37C; mix with 2.5 ml top agar containing .05 mM biotin + histidine; then grow the 
cells for 48 hr (YG1024) or 72 hr (YG1029); and then count the formed colonies.  
 
Mammalian Cell clastogenic damage assay of NIST SRM 2975 DPM used the micronucleus 
assay in V79 cells at 2x106 cells / ml medium, grown 24h prior to challenge.  The positive 
control was MNNG.  The surfactant was DPPC ultrasonically dispersed in physiological sterile 
saline to a dispersion concentration of 2.5 mg DPPC / ml PSS. The same DPM and DPPC stock 
dispersion concentration of 1 mg DPM/ 2.5 mg DPPC / 1 ml PSS was prepared, but diluted with 
PSS to  samples of 40, 120,180 microgram DPM / ml PSS.  The solvent preparation was to 
extract DPM with acetone, evaporate the extract, dissolve the extract residue in DMSO to 2 mg 
DPM extract / ml DMSO, and subsequently dilute this stock with PSS to provide samples of  
200, 600, 900 microgram extract in 5 ml medium.  The assay then used 24 h incubation of V79 
cells in 5 ml medium with 40, 120, 180 microgram/ml of (X) solvent extract of DPM or (D) 
DPPC-dispersed DPM.   After 24 hr challenge the cells were rinsed, 5 ml medium replaced; and 
incubated another 24 hr.  cells then were harvested, fixed, stained and slides prepared for optical 
microscopy examination, scoring 6 x 1000 cells (n=6) for each concentration for each of 2 runs. 
 
Mammalian cell DNA damage assay of the NIST 2975 soot used the single-cell gel 
electrophoresis assay for single- or double-strand DNA damage under the same V79 cell system 
assays preparations as the micronucleus induction assays. After 24 hr challenge then SCGE was 
performed , and 100 cells  read for each treatment for each of two runs.   
 
Figure 5 shows comparable activity for bacterial mutagenicity induction by a given mass of 
DPM dispersed in DPPC surfactant versus the activity of the solvent extract of the same mass of 
DPM.  Figure 6.a shows micronucleus induction by a given mass of DPM dispersed in DPPC 
surfactant, but versus the activity of an equal mass of extract.  Figure 6.b shows the data of 
Figure 6.a normalized to the amount of DPM from which the extract was taken; that is 
comparing the activity of a concentration of DPPC-dispersed DPM versus the activity of the 
(smaller) amount of dissolved organics that would be extracted from that same amount of soot.  
In the case of this particular NIST SRM2975 DPM, there were only 4% extractables.  Figure 7 
similarly shows the exacerbated activity for particle-borne genotoxicants in the SCGE DNA-
damage assay.  These results indicate that a synergistic affect on the expression of genotoxicity 
in mammalian cells can occur for organic genotoxicants when borne on respirable ultrafine 
carbonaceous soot.  
 
In addition, a particulate carbon black sample containing no extractable organic genotoxicants, 
and the residual particulate material of the NIST 2975 DPM that survived acetone extraction 
were mixed into DPPC dispersion and assayed in the mammalian cell micronucleus assay.  
Neither was active.  This was to test for a possible contribution to the genotoxic activity due to 
the ultrafine particulate matter per se, that is, due for genotoxic activity associated only with the 
ultrafine size of the particles.  The data suggest that the presence of genotoxicants on the 
particles was necessary for the genotoxic activity; but that for this NIST sample the combination 
of genotoxicants on the ultrafine particle significantly exacerbated the genotoxic activity for 
mammalian cells, but not as strongly for bacterial mutagenic activity. Additional data is 
contained in the 2006 DEER Conference presentation [7].  Additional assays are being 
performed and the data is being analyzed toward a report for peer-reviewed journal submission, 
under the new US Department of Energy – NIOSH Interagency Agreement (IAA #06-08: DE-
A126-06NT42821): “Novel collection and toxicological analysis techniques for IC engine 
exhaust particulate matter”, begun 4Q06. 
 
C. Collecting DPM to Retain Ultrafine Particle Factors Affecting Toxicity  
 
In vitro genotoxic activities assayed on organic solvent-extractable materials from DPM can vary 
greatly and systematically with diesel engine system mode of operation, fuel, and other 
engineering parameters.  Further, the NIOSH studies of surfactant-dispersed DPM genotoxicity, 
show that genotoxic activities can be expressed by some DPM containing organic genotoxicants, 
as non-dissolved particulate dispersion in a principal component of lung surfactant; and that for 
some DPM the genotoxic activity for mammalian cells is quantitatively greater for the 
genotoxicants when they are ultrafine-particulate-borne, compared to their activities as solvent 
extracts.  
 
Another consideration for filter collection and in vitro bioassay of DPM is the possibility of 
anoamlus conditioning of ultrafine DPM during filter collection by irreversible agglomeration of 
the ultrafine aerosol particles or chemical modification of the DPM held on the filter by lengthy 
exposure to heteroatomic comounds in the exhaust.  
 
Collection of aerosolized DPM from the exhaust directly into surfactant dispersion for direct 
bioassay suggests a basis for sampling and testing ultrafine particulate exhaust materials with 
low mass of emissions vis a vis current emission standards, but with ultrafine particle size and 
associated high specific surface areas.   
 
A first quantitative test of a sampling system for the collection of diesel exhaust ultrafine 
particulate material directly into DPPC/saline surrogate lung surfactant was been initited under 
this DOE-NIOSH IAA.  This involved a collaborative effort by NIOSH, the US Department of 
Energy – Office of FreedomCar and Vehicle Technology, West Virginia University (WVU), and 
the University of Southern California (USC). Samples were collected from a commercial diesel 
engine operated on a dynamometer in the WVU diesel engine test lab, using a USC humidifier 
system to condition the exhaust stream to prepare ultrafine particles for efficient collection in a 
surfactant-laden impinger.  Genotoxicity assays on the collected samples are underway and will 
be completed under the new DOE-NIOSH IAA.  The concept is the subject of an Employee 
Invention Report filed with the US Centers for Disease Control, with joint DOE, NIOSH, West 
Virginia University, and University of Southern California authorship.  Results will guide 
modification of the sampler and sampling protocol with subsequent additional testing and 
application in the new DOE-NIOSH IAA begun in late FY06.   
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D.  Research to Practice: 
 
 
The US Environmental Protection Agency (EPA) is requiring more stringent controls of diesel vehicle 
exhaust emissions of respirable particulate matter and oxides of nitrogen; these are to be implemented  
over the next several years, beginning in 2007. US DOE and industry-supported research groups are 
mounting studies of prototype diesel engines with integrated emission control technologies toward 
meeting those exhaust emission control requirements. At the same time, there is concern with the 
possibility for production and release of ultrafine particulate exhaust materials from the new systems.  
While very low in mass of emissions, there is concern for ultrafine sized or “nano-particulate” matter in 
the final exhaust. DPM can have very small particle size, below 0.1 micrometer. That size itself or the 
associated high specific surface area of such ultrafine particles, that is, surface area per unit mass of ten 
to a hundred times that of typical fine-sized respirable particles, may present unknown respiratory or 
other health hazard. That is, there is expressed interest by government and industry for emissions of 
ultrafine particles from new technologies. Mass measures of particulate emissions may not be fully 
predictive of health consequences. In vitro genotoxic activity of the organic extracts of in diesel exhaust 
vary with engineering parameters.   
 
Determination of the effects of engine design and operational parameters and new emission control 
technologies on exhaust PM genotoxic activity, measured so as to retain particulate phase properties and 
effects on genotoxicant bioavailability and activity, are needed in order to readily identify potential 
ultrafine particulate emissions with such heightened toxicity, and to inform diesel engine and exhaust 
control system development to control such emissions.  The surfactant-mediated in vitro testing methods 
from these studies provide a basis for short-term genotoxicity assays modeling some insoluble-particle 
interactions in the lung that than can affect the in vitro expression of toxicity.  Collection of diesel 
exhaust stream aerosol DPM directly into surfactant dispersion might permit retention of critical 
particulate properties significantly affecting the expression of DPM toxicities as they would occur upon 
deposition in the lung.  Such collection and assay may be feasible, in time and effort, for on-going 
guidance of diesel emission control technology development, and to complement government – industry 
developmental testing of prototype diesel emission control systems to meet the new EPA diesel emission 
standards. 
 
There now is general concern in industry and government for unexpected hazards that might be 
associated with exposures to ultrafine particles in the burgeoning field of “nano-particle” technology.  
Results of these DOE-NIOSH studies of ultrafine diesel exhaust particulate materials, have been 
solicited for consultation, presentation or review publication to inform toxicological investigations for 
emerging “nanoparticle” production or use [ 9,10,11,12], as well as for investigations of new diesel 
engine control technologies [13].    
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